At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Aug 24, 2026 at 16:19 ET
Three insiders at Arcutis Biotherapeutics sold a total of $198K in open-market sales over a 7-day window, with the largest sale ($124K) by Director Howard Welgus. The total value is only ~0.006% of the company's $3.2B market cap, making this a trivial cluster by proportionality. No cross-filing context suggests distress or material negative news; the cluster is neutral and low-impact.
- Three insiders sold shares totaling $198K in open-market sales from Aug 13-20, 2026.
- Total sales represent only ~0.006% of Arcutis's $3.2B market cap, well below the 0.1% materiality threshold.
- Director Howard Welgus accounted for the largest sale at $124K; Director Terrie Curran also exercised non-cash derivatives.
- No cross-filing context indicates distress, earnings miss, or material negative news.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access